论文部分内容阅读
目的:探讨美托洛尔治疗心力衰竭的临床效果。方法:收集2012年2月至2016年2月我院慢性心力衰竭的患者作为研究对象,疾病符合Framingham诊断标准,随机分为研究组和对照组,各60例。两组基础治疗方案为洋地黄、利尿剂、硝酸盐类及ACEI,研究组在基础治疗上加用美托洛尔。对比两组治疗前后静息状态下血压及两组治疗前后Levf、BNP值。结果:两组治疗前静息状态下血压、Levf及BNP值比较无差异(P>0.05);两组治疗后静息状态下血压、Levf及BNP值比较差异显著(P<0.05)。结论:美托洛尔能够明显改善心力衰竭患者症状,改善心功能。
Objective: To investigate the clinical effect of metoprolol in the treatment of heart failure. Methods: From February 2012 to February 2016, patients with chronic heart failure in our hospital were collected. The patients were diagnosed as Framingham. All patients were randomly divided into study group and control group, with 60 cases in each group. Two groups of basic treatment programs for digitalis, diuretics, nitrates and ACEI, the study group in the basic treatment with metoprolol. Before and after treatment, the two groups were compared before and after treatment of blood pressure and Levf, BNP value before and after treatment. Results: There was no significant difference in blood pressure, Levf and BNP between the two groups before resting (P> 0.05). The resting blood pressure, Levf and BNP of the two groups after treatment were significantly different (P <0.05). Conclusion: Metoprolol can significantly improve the symptoms of heart failure patients and improve cardiac function.